← Open Payments lookup

ELIZABETH BRIGHT: Open Payments

NPI 1770138000 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,080 in 50 payments from 12 companies in 2025. Trend: 2023 $1,699 · 2024 $801 · 2025 $1,080

Food & beverage: $1,076Education: $4
CompanyPaymentsAmount
Axsome Therapeutics, Inc.9$345
Alkermes, Inc.15$185
Neurocrine BioSciences, Inc.5$125
Supernus Pharmaceuticals, Inc.4$118
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$85
E.R. Squibb & Sons, L.L.C.2$44
Collegium Pharmaceutical, Inc.2$42
Teva Pharmaceuticals USA, Inc.2$34
Takeda Pharmaceuticals U.S.A., Inc.2$33
ABBVIE INC.1$29

Products named: Auvelity, ARISTADA, INGREZZA, Qelbree, CAPLYTA, LYBALVI, COBENFY, Jornay PM.

Industry payments across LA — which companies pay providers there.